This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohmachi, T. Articles by Mori, M. Search for Related Content PubMed PubMed Citation Articles by Ohmachi, T. Articles by Mori, M.

Clinical Significance of TROP2 Expression in Colorectal Cancer

Authors' Affiliations: ¹ Department of Surgery and Molecular Oncology, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan; ² Department of Surgery, Jikei University School of Medicine, Tokyo, Japan; and ³ Core Research for Evolutional Science and Technology, Japan Science and Technology Agency, Saitama, Japan

Requests for reprints: Masaki Mori, Department of Surgery and Molecular Oncology, Medical Institute of Bioregulation, Kyushu University, 4546 Tsurumihara, Beppu 874-0838, Japan. Phone: 81-977-27-1650; Fax: 81-977-27-1651; E-mail: mmori{at}beppu.kyushu-u.ac.jp.

Purpose and Experimental Design: To identify cancer-related genes, the expression profiles of colorectal cancer cells and normal epithelial cells were examined and compared using laser microdissection and cDNA microarray analysis. From these combined techniques, several cancer-related genes, including TROP2, were identified. TROP2 is known as a calcium signal transducer and is highly expressed in several types of tumors. However, no studies have investigated the significance of TROP2 expression in colorectal cancer. Thus, the expression status of TROP2 was investigated in 74 colorectal cancer samples by quantitative real-time reverse transcription-PCR and immunohistochemical studies.

Results: Laser microdissection and cDNA microarray analysis showed that there were 84 overexpressed genes in cancer cells. One of the highly overexpressed genes was TROP2. Quantitative real-time reverse transcription-PCR showed that TROP2 expression in cancer samples was significantly higher than in normal samples (P < 0.001). The samples were divided into high (n = 26) and low (n = 48) TROP2 expression groups. The cases with high TROP2 expression showed a higher frequency of liver metastasis (P = 0.005) and more cancer-related death (P = 0.046). Those cases also had an inclination of deeper depth of invasion (P = 0.064) and more lymph node metastasis (P = 0.125). Interestingly, the patients with high TROP2 expression tumors had poorer prognosis (P = 0.0036). Multivariate analysis showed that TROP2 expression status was an independent prognostic factor (relative risk, 2.38; 95% confidence interval, 1.29-4.74; P < 0.01).

Conclusion: TROP2 is one of the cancer-related genes that correlates with biological aggressiveness and poor prognosis of colorectal cancer. Thus, TROP2 is a possible candidate gene for diagnosis and molecular target therapy of colorectal cancer.

This article has been cited by other articles:

				K. Sakashita, K. Mimori, F. Tanaka, Y. Kamohara, H. Inoue, T. Sawada, K. Hirakawa, and M. Mori Prognostic Relevance of Tensin4 Expression in Human Gastric Cancer Ann. Surg. Oncol., September 1, 2008; 15(9): 2606 - 2613. [Abstract] [Full Text] [PDF]

				K. Sakashita, K. Mimori, F. Tanaka, Y. Kamohara, H. Inoue, T. Sawada, K. Hirakawa, and M. Mori Clinical Significance of Loss of Fhl1 Expression in Human Gastric Cancer Ann. Surg. Oncol., August 1, 2008; 15(8): 2293 - 2300. [Abstract] [Full Text] [PDF]

				K. Motoyama, F. Tanaka, Y. Kosaka, K. Mimori, H. Uetake, H. Inoue, K. Sugihara, and M. Mori Clinical Significance of BMP7 in Human Colorectal Cancer Ann. Surg. Oncol., May 1, 2008; 15(5): 1530 - 1537. [Abstract] [Full Text] [PDF]

				S. K. Chan, O. L. Griffith, I. T. Tai, and S. J.M. Jones Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 543 - 552. [Abstract] [Full Text] [PDF]

				C. E. Reed, A. Graham, R. S. Hoda, A. Khoor, E. Garrett-Mayer, M. B. Wallace, and M. Mitas A simple two-gene prognostic model for adenocarcinoma of the lung J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 627 - 634. [Abstract] [Full Text] [PDF]

				T. Yokoe, F. Tanaka, K. Mimori, H. Inoue, T. Ohmachi, M. Kusunoki, and M. Mori Efficient Identification of a Novel Cancer/Testis Antigen for Immunotherapy Using Three-Step Microarray Analysis Cancer Res., February 15, 2008; 68(4): 1074 - 1082. [Abstract] [Full Text] [PDF]

				J. Wang, R. Day, Y. Dong, S. J. Weintraub, and L. Michel Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers Mol. Cancer Ther., February 1, 2008; 7(2): 280 - 285. [Abstract] [Full Text] [PDF]

				Y. Kosaka, H. Inoue, T. Ohmachi, T. Yokoe, T. Matsumoto, K. Mimori, F. Tanaka, M. Watanabe, and M. Mori Tripartite Motif-Containing 29 (TRIM29) Isa Novel Marker for Lymph Node Metastasis in Gastric Cancer Ann. Surg. Oncol., September 1, 2007; 14(9): 2543 - 2549. [Abstract] [Full Text] [PDF]

				M. Takaoka, T. Nakamura, Y. Ban, and S. Kinoshita Phenotypic Investigation of Cell Junction-Related Proteins in Gelatinous Drop-Like Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1095 - 1101. [Abstract] [Full Text] [PDF]